NuVasive Sees Flattening Recovery Curve for Spinal Surgeries

NuVasive logo

NuVasive reported 3Q20 orthopedic revenue of USD $295.3 million, +1.5% vs. 3Q19. Strong international performance in the Asia Pacific and select European markets helped the company recover faster than expected. While some spinal hardware product lines grew in the high single digits, declines in legacy cervical products partially offset those...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us